Advantages and Disadvantages of the HPV Vaccine in Adolescent Girls: An Ethical Case Study
Drexel University
Human papillomaviruses (HPV) are a group of more than 40 types of viruses that infect the genital areas, throats (recurrent respiratory papillomatosis), and mouths of males and females and is the number one most common sexually transmitted disease (Center for Disease Control and Prevention [CDC], 2009). It is spread by genital contact. It is most easily spread by vaginal and anal sex, but also through oral sex and even just genital-to-genital (skin-to-skin). In 90% of people that contract HPV, their own immune system clears it up within two years, most never even developing any symptoms from it (CDC, 2009). Out of the many types of HPV types, most end up causing warts on one of the above-mentioned areas, while a certain few are known to cause cervical cancer. Lockwood-Rayermann & McIntyre (2009) state that “[t]he most common oncogenic/high-risk virus types worldwide and in the United States are Types 16, 18, 31, 45, and 52; 11% of invasive cervical cancers in the United States are caused by Types 16 and 18 (55% by Type 16 and 22% by type 18). HPV Types 31, 45, and 52 comprise another 8% of all cases.” Cervical cancer is usually not detected until it is quite advanced, which is why women should get screened for cervical cancer regularly. There is also another precaution women can take. The Food and Drug Administration approved the very first vaccine to prevent cervical cancer by the types of HPV that cause it in June of 2006 (Thomas, 2008). This vaccine, being new, and therein little is known about its long term effects, has caused ethical debates about the use of it, particularly in adolescent girls. Thomas (2008) mentions that the CDC recommended, by a unanimous vote, that girls aged 11 to 12 years old receive this new HPV vaccine.